Table 1.
Demographics at Preconception (>10 Months Before Delivery) for HIV-Infected Women, HIV-Uninfected Women, and the Two Groups Combined (n=244)
| |
HIV status |
|
|
|---|---|---|---|
| Variables | HIV-infected n=139 n (%) | HIV-uninfected n=105 n (%) | Overall sample n=244 n (%) |
| Age (mean, SD)** | 30.37 (5.37) | 28.08 (5.90) | 29.38 (5.71) |
| Race | |||
| African American | 90 (65) | 60 (57) | 150 (62) |
| Hispanic | 37 (27) | 38 (36) | 75 (31) |
| White | 27 (19) | 16 (15) | 43 (18) |
| At least high school graduate or equivalent | 75 (54) | 58 (55) | 133 (55) |
| Currently employed | 52 (37) | 43 (41) | 95 (39) |
| Currently married | 57 (41) | 39 (37) | 96 (39) |
| Average household Income (≤$12,000/year) | 77 (55) | 54 (51) | 131 (54) |
| Carrying insurance** | 111 (80) | 67 (64) | 178 (73) |
| Current number of sex partners (≥2)*** | 24 (17) | 40 (38) | 64 (26) |
| Trying to get pregnant | 88 (63) | 76 (72) | 164 (67) |
| Mental health services† | 24 (17) | 10 (10) | 34 (14) |
| Recent usea | |||
| Smoking | 66 (48) | 46 (44) | 112 (46) |
| Alcohol | |||
| Abstainer | 70 (50) | 41 (39) | 111 (46) |
| Light (<3 drinks/week) | 46 (33) | 41 (39) | 87 (36) |
| Moderate (3–13 drinks/week) | 18 (13) | 13 (12) | 31 (12) |
| Heavy (≥14 drinks/week) | 5 (4) | 10 (10) | 15 (6) |
| Marijuana/hash† | 28 (20) | 32 (31) | 60 (25) |
| Crack/freebase cocaine | 15 (11) | 11 (11) | 26 (11) |
| Cocaine | 7 (5) | 8 (8) | 15 (6) |
| Heroin | 3 (2) | 7 (7) | 10 (4) |
| Composite crack, cocaine, and/or heroin | 19 (14) | 18 (17) | 37 (15) |
| Disease | |||
| CD4 number | |||
| >500 | 59 (42) | - | - |
| ≥200 and ≤500 | 69 (50) | - | - |
| <200 | 11 (8) | - | - |
| Viral load (HIV RNA, copies/mL) | |||
| Undetectable | 43 (31) | - | - |
| <10,000 | 58 (42) | - | - |
| ≥10,000 | 38 (27) | - | - |
| Medication use | |||
| HAART | 47 (34) | - | - |
| Non-HAART | 22 (16) | - | - |
| ARV naive | 70 (50) | - | - |
| Medication compliance (≥95%)b | 36 (77) | - | - |
| Intervals (days: Mean, SD) | |||
| Preconception (>300 days before delivery) | 440.30 (88.49) | 453.81 (123.66) | 446.11 (105.05) |
| Pregnancy (≤300 days before delivery) | 116.76 (74.32) | 111.66 (76.58) | 114.57 (75.19) |
| Postpartum (≤365 days after delivery) | 146.92 (82.10) | 143.29 (83.83) | 145.36 (82.70) |
a
Recent use refers to within 6 months of the preconception Women's Interagency HIV Study (WIHS) visit.
b
Data were only available on 47 of the 69 women taking medication because this information was not collected until October 1998 in the WIHS. Therefore, the percentage of women who were medication compliant is based on 36 of 47 women.
***
p<0.001; **p<0.01.
†
p>0.05 and p<0.10.
ARV, antiretroviral; HAART, highly active antiretroviral therapy; SD, standard deviation.